Robert Negrin, MD

The faculty open by framing the current state of allogeneic stem cell transplantation, describing an era in which a suitable donor can be identified for the vast majority of patients and in which advances in upfront treatment of hematologic malignancies are bringing more patients into remission and therefore into transplant eligibility.

Amandeep Salhotra, MD, and Robert Negrin, MD, sit down with Chandler Park, MD, FACP, to discuss the latest abstracts in graft-vs-host disease presented during the 2025 ASH Annual Meeting & Exposition.